AstraZeneca Kidrey Drug Trial Successful By Investing.com

© Reuters.

Investing.com — Here is a roundup of regulatory releases from the London Stock Exchange on Friday, 8th November. Please refresh for updates.

  • Pharma group AstraZeneca (LON:) reported successful Phase III trials for its roxadustat drug, used to treat anemia in patients suffering from chronic kidney disease.
  • It said it expects to make a regulatory submission for the drug to be approved in the U.S. by year-end.

Source link

Share with your friends!

Products You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *

Get The Latest Investing Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.